Synergy Medicines Private Limited
About Synergy Medicines Private Limited
Data last updated:
Synergy Medicines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC153054.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shirin Hamied and Rumana Hamied.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.51 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹10.53 Lakh (net margin 51.3%) and EBITDA of ₹16.13 Lakh (EBITDA margin 78.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Synergy Medicines Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synergy Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synergy Medicines is real estate activities. In detail, this covers real estate activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real estate activities | 68 | Real estate activities |
To see the full business activity and turnover split of Synergy Medicines Private Limited, buy the company report.
Financials of Synergy Medicines Private Limited
FY 2025 filings availableSynergy Medicines Private Limited reported revenue of ₹20.51 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 5% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 78.6% | ||||
| Net Profit Margin | 51.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synergy Medicines Private Limited, buy the company report.
Board of directors of Synergy Medicines Private Limited
Synergy Medicines has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shirin Hamied Also directs: Hamsons Laboratories LLP, Shree Riddhi Chemicals LLP, MN Rajkumar Garments LLP and 2 more | Director | 15 Dec 2014 | 11 Years 11 Months | Current |
| Rumana Hamied | Nominee Director | 11 Aug 2023 | 3 Years 3 Months | Current |
| Shankar Srinivasan Also directs: MN Rajkumar Garments LLP, Nce Research Labs Private Limited, Famid Sports Private Limited and 4 more | Nominee Director | 23 Dec 2016 | 9 Years 10 Months | Current |
Auditor
Synergy Medicines Private Limited is audited by ANAND MEHTA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANAND MEHTA & ASSOCIATES | FY 2018 | 127305W/W100058 |
Shareholding
The shareholding of Synergy Medicines Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synergy Medicines Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synergy Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synergy Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Synergy Medicines Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Synergy Medicines Private Limited has 7 board changes on record since 2014: 3 appointments and 4 cessations. The latest: Rumana Hamied was appointed as Nominee Director on 11 Aug 2023.
Frequently asked questions
Synergy Medicines is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 2005 (21+ years old) and is registered under CIN U24230MH2005PTC153054.
Synergy Medicines has 3 current directors:
- Shirin Hamied - Director
- Rumana Hamied - Nominee Director
- Shankar Srinivasan - Nominee Director
The latest financial statements of Synergy Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Synergy Medicines is U24230MH2005PTC153054. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synergy Medicines was incorporated on 05 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Rumana Hamied was appointed as Nominee Director on 11 Aug 2023. Srinivas Hariharan ceased to be Director on 11 Aug 2023. Shankar Srinivasan ceased to be Additional Director on 14 Sep 2017. Synergy Medicines has 7 board changes on record in total.
The registered office of Synergy Medicines is at 12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001.
Synergy Medicines operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Synergy Medicines is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.
Synergy Medicines can be reached at its registered office: 12 Gunbow Street Fort, Mumbai, Maharashtra, India – 400001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
